GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in …
…, C Ribeiro, L Teixeira, P Ávila-Ribeiro… - Annals of the …, 2020 - ard.bmj.com
… By week 24, patients treated with golimumab plus MTX exhibited significantly greater
improvements in DSS relative to MTX monotherapy (median change of 5 vs 2 points, respectively; p…
improvements in DSS relative to MTX monotherapy (median change of 5 vs 2 points, respectively; p…
Sex differences in axial spondyloarthritis: data from a Portuguese spondyloarthritis cohort.
…, E Vieira-Sousa, N Khmelinskii, P Ávila-Ribeiro… - ARP …, 2022 - europepmc.org
Background Axial spondyloarthritis (axSpA), particularly ankylosing spondylitis was
historically considered a male's disease and has been under-recognized in women. Emerging …
historically considered a male's disease and has been under-recognized in women. Emerging …
Effect of Comedication With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With …
…, D Van Der Heijde, P Ávila‐Ribeiro… - Arthritis & …, 2016 - Wiley Online Library
Objective To evaluate whether use of comedication with conventional synthetic disease‐modifying
antirheumatic drugs (csDMARDs) influences the retention of tumor necrosis factor …
antirheumatic drugs (csDMARDs) influences the retention of tumor necrosis factor …
Real-world longterm effectiveness of tumor necrosis factor inhibitors in psoriatic arthritis patients from the Rheumatic Diseases Portuguese Register
E Vieira-Sousa, M Eusébio, P Ávila-Ribeiro… - The Journal of …, 2020 - jrheum.org
Objective. To assess longterm effectiveness of tumor necrosis factor inhibitors (TNFi) in patients
with psoriatic arthritis (PsA) registered in the Rheumatic Diseases Portuguese Register, …
with psoriatic arthritis (PsA) registered in the Rheumatic Diseases Portuguese Register, …
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis …
…, F Iannone, MJ Santos, P Avila-Ribeiro… - Annals of the …, 2021 - ard.bmj.com
Background Comedication with conventional synthetic disease-modifying antirheumatic drugs
(csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively …
(csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively …
Complicações orais em pacientes tratados com radioterapia ou quimioterapia em um hospital de Santa Catarina
D de Freitas Floriano, PFA Ribeiro… - … de Odontologia da …, 2017 - publicacoes.unicid.edu.br
Objetivo: Este estudo se propôs a avaliar as complicações orais em pacientes tratados com
radioterapia ou quimioterapia. Introdução: Mesmo que a radioterapia e a quimioterapia …
radioterapia ou quimioterapia. Introdução: Mesmo que a radioterapia e a quimioterapia …
Cooperativismo agropecuário e suas contribuições para o empoderamento dos agricultores familiares no submédio São Francisco: o caso da associação de …
KÁ Ribeiro, DC do Nascimento… - Revista Teoria e Evidência …, 2013 - seer.upf.br
Este trabalho tem por objetivo apresentar os benefícios e as vantagens que as cooperativas
agropecuárias podem trazer para o fortalecimento da agricultura familiar, em especial dos …
agropecuárias podem trazer para o fortalecimento da agricultura familiar, em especial dos …
[PDF][PDF] Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis–2016 update
PM Machado, M Cerqueira, P Ávila-Ribeiro… - Acta Reumatologica …, 2017 - comum.rcaap.pt
Objective: To update the recommendations for the treatment of axial spondyloarthritis (axSpA)
with biological therapies, endorsed by the Portuguese Society of Rheumatology. Methods: …
with biological therapies, endorsed by the Portuguese Society of Rheumatology. Methods: …
Hepatitis B vaccination associated with low response in patients with rheumatic diseases treated with biologics
VC Romão, P Ávila-Ribeiro, MJ Gonçalves… - RMD open, 2023 - rmdopen.bmj.com
Background Hepatitis B virus (HBV) vaccination is recommended for non-immunised
patients with rheumatic diseases starting biological disease-modifying antirheumatic drugs (…
patients with rheumatic diseases starting biological disease-modifying antirheumatic drugs (…
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
…, H Relas, B Michelsen, P Avila Ribeiro… - …, 2022 - academic.oup.com
… (P-values <0.001). Following adjustment, the overall delta-ASDAS-CRP remained highly
significant (P = 0.008), although this was not the case for the overall delta-BASDAI (P = 0.48). …
significant (P = 0.008), although this was not the case for the overall delta-BASDAI (P = 0.48). …